Five current, individually attributable price targets were reviewed to calculate the central target. JPMorgan's Tomohiko Sano holds a $100 target (November 2026), Northland Securities' Bobby Brooks stands at $139 (November 2026), Oppenheimer's Christopher Glynn is at $115 (October 2026), Maxim Group lists $128 (August 2026), and Beacon Securities' Russell Stanley is at $130 (June 2026). Their average is about $122.40, which rounds to a central target of $120. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The $100-to-$139 spread shows that analysts differ markedly. Cautious views lean on valuation after a multi-year run; more bullish views highlight underappreciated growth beyond the company's established U.S. Navy submarine and carrier content. Notably, two targets were trimmed recently — JPMorgan lowered its target from $120 to $100 and Oppenheimer cut from $130 to $115 — even as both firms kept constructive ratings. That pattern reflects confidence in the business coupled with concern that much of the good news is already priced in.
As of early November 2026, GHM traded near $78, up sharply after its latest quarterly report. The stock's 52-week range is roughly $52.57 to $125.82, meaning shares sit well below their prior high but far above their low. Reaching $120 from about $78 implies a rise of approximately 54%, a very large move that would require sustained earnings beats, multiple expansion, or both.
The fundamental backdrop is supportive in parts. Management has guided fiscal 2027 revenue to $285–$295 million with adjusted EBITDA of $35–$40 million, and introduced a three-year plan targeting 8%–10% annual organic revenue growth and 14%–16% adjusted EBITDA margins. Analysts project fiscal 2027 revenue near $290 million, roughly 18% above the prior year.
Several verified factors could underpin a climb toward $120. Graham's exposure to U.S. Navy submarines and aircraft carriers offers long-cycle, mission-critical revenue visibility. The 2022 Barber-Nichols acquisition expanded the company into space and undersea warfare, and management is shifting from one-off custom projects toward scalable, repeatable products. The company's track record of exceeding organic growth targets — 16% in fiscal 2026, 12% in fiscal 2025, and 17% in fiscal 2024 — lends credibility to its outlook.
M&A remains a potential catalyst, with a full pipeline and targets in the $20–$100 million revenue range. Liquidity above $100 million provides flexibility, while a planned move toward a roughly 50/50 defense-commercial revenue mix could diversify growth and support margins.
The principal obstacle is valuation. GHM trades at a trailing P/E near 68 and a forward P/E above 40, leaving little room for disappointment. The recent target reductions by JPMorgan and Oppenheimer signal that some analysts believe the stock's rally has outpaced near-term fundamentals. A slower-than-expected ramp in new programs, defense-budget timing, or integration and execution risk around acquisitions could compress the multiple quickly.
Because a large share of the bull case rests on defense spending, any shift in budgetary priorities or program delays would weigh on sentiment. The company's transition to a scalable product model also carries execution uncertainty.
Technically, the $100 level stands out as both a psychological round number and the lowest current analyst target, potentially acting as initial resistance. The prior 52-week high near $125.82 sits just above the $120 central target, meaning a move toward the target would retest territory shares previously occupied before pulling back. On the downside, the low-$70s area, where the stock consolidated before its latest earnings surge, represents a meaningful support zone.
Analyst price targets generally reflect a research horizon of about 12 months, though individual timelines can vary and no single date is guaranteed. Investors should monitor Graham's quarterly results and any changes to fiscal 2027 guidance, progress toward the three-year margin plan, acquisition announcements, and defense-budget developments. Analyst revisions will matter most: whether targets continue to drift lower or begin to climb again will signal how the Street is weighing growth against valuation.
In my own workflow, Tickeron’s AI Daily Buy/Sell Signals provide a practical way to stay on top of momentum shifts for names that have already moved sharply. The system scans thousands of stocks daily and flags Buy, Sell, or Hold signals based on technical and AI-driven factors. For a stock like GHM that has rallied post-earnings, these signals offer an efficient complement to fundamental work when evaluating whether momentum can extend.
The $120 central target is the rounded average of five current analyst price targets spanning $100 to $139. From a price near $78, reaching it would require a very large advance of roughly 54%. The bull case rests on defense and space demand, expanding margins, and a credible acquisition story; the bear case centers on a rich valuation and recent downward target revisions. Analysts broadly rate the stock a Buy, but the wide target range shows genuine uncertainty about how much growth is already reflected in the price. Investors should watch earnings, guidance, and target revisions closely rather than treating the $120 figure as a forecast of where the stock will trade.
One tool I return to regularly is Tickeron’s AI Daily Buy/Sell Signals. It helps me monitor signals across a broad universe without constant manual chart review, which is especially useful when tracking names that have already made sizable moves. The daily updates give a quick read on whether conditions are shifting, and I often cross-reference them with my fundamental notes before making any adjustments.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The RSI Indicator for GHM moved out of oversold territory on October 26, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 17 similar instances when the indicator left oversold territory. In 15 of the 17 cases the stock moved higher. This puts the odds of a move higher at 88%.
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on GHM as a result. In 85 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for GHM just turned positive on October 28, 2026. Looking at past instances where GHM's MACD turned positive, the stock continued to rise in 35 of 42 cases over the following month. The odds of a continued upward trend are 83%.
Following a +12.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where GHM advanced for three days, in 249 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GHM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.
GHM broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for GHM entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 39 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.
The Tickeron Seasonality Score of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. GHM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 78 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.765) is normal, around the industry mean (3.805). P/E Ratio (73.604) is within average values for comparable stocks, (36.482). Projected Growth (PEG Ratio) (2.511) is also within normal values, averaging (1.879). Dividend Yield (0.006) settles around the average of (0.032) among similar stocks. P/S Ratio (3.693) is also within normal values, averaging (186.943).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of vacuum and heat transfer equpiment
Industry IndustrialMachinery